To gain deeper insights into the immune evasion mechanisms driven by TLR stimulation in 4T1 breast cancer cells, we conducted a comprehensive evaluation of the gene expression of key immune checkpoint molecules, including PD-L1, Gal-9, and PVR. The gene discussed is PVR; the disease is breast carcinoma.